PDA-FDA 2011 to Focus on Compliance
Meeting Co-Chair Susan Schniepp provides insight into this year's regulatory conference.
Co-Chair of the 2011 PDA-FDA Joint Regulatory Conference Susan Schniepp talks with Angie Drakulich, senior managing editor of Pharmaceutical Technology, about what to expect at this year's meeting. Schniepp is vice-president of quality for OSO Biopharmaceuticals and a member of PharmTech's editorial advisory board. FDA's enforcement strategy, compliance, industry best practices and more are addressed.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
